Kevin Bruce
Geschäftsführer bei Censo Biotechnologies Ltd.
Profil
Kevin Bruce is currently the Chief Operating Officer at Censo Biotechnologies Ltd.
Prior to this, he held the position of Chief Operating Officer at Roslin Cell Therapies Ltd.
from 2019 to 2023.
Aktive Positionen von Kevin Bruce
Unternehmen | Position | Beginn |
---|---|---|
Censo Biotechnologies Ltd.
Censo Biotechnologies Ltd. Miscellaneous Commercial ServicesCommercial Services Censo Biotechnologies Ltd. operates as stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. It offers human bio-sample procurement, IPSC generation & genome editing, IPSC differentiation, assay development and screening services. The company is headquartered in Midlothian, the United Kingdom. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Kevin Bruce
Unternehmen | Position | Ende |
---|---|---|
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022. | Geschäftsführer | 03.10.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Censo Biotechnologies Ltd.
Censo Biotechnologies Ltd. Miscellaneous Commercial ServicesCommercial Services Censo Biotechnologies Ltd. operates as stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. It offers human bio-sample procurement, IPSC generation & genome editing, IPSC differentiation, assay development and screening services. The company is headquartered in Midlothian, the United Kingdom. | Commercial Services |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022. | Health Technology |